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Running title: m6A regulates stability of R-loops. 28 
Introductory paragraph: R-loops are nucleic acid structures formed by an RNA:DNA 29 
hybrid and unpaired single stranded DNA that represent a source of genomic instability in 30 
mammalian cells1-4. Here we show that N6-methyladenosine (m6A) modification, 31 
contributing to different aspects of mRNA metabolism5, 6, is detectable on the majority of 32 
RNA:DNA hybrids in human pluripotent stem cells (hPSCs). We demonstrate that m6A-33 
containing R-loops accumulate during G2/M and are depleted at G0/G1 phases of the cell 34 
cycle and that the m6A reader promoting mRNA degradation, YTHDF27, interacts with R-35 
loops-enriched loci in dividing cells. Consequently, YTHDF2 knockout leads to increased R-36 
loop levels, cell growth retardation and accumulation of γH2AX, a marker for DNA double-37 
strand breaks, in mammalian cells. Our results suggest that m6A regulates accumulation of R-38 
loops, implying a role for this modification in safeguarding genomic stability.   39 
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Main Text: Dynamic methylation of adenosine in RNA (N6-methyladenosine, m6A) has 40 
been implicated in regulation of different aspects of mRNA metabolism in mammals by 41 
numerous studies5, 6. Although m6A is abundant in eukaryotic transcriptomes, its DNA 42 
counterpart, N6-methyldeoxyadenosine (6mA) was previously thought to be restricted to 43 
unicellular organisms and only recently has been shown to exist in non-negligible quantities 44 
in metazoan DNA8-10. Despite the fact 6mA is reportedly widespread in fungal genomes11, its 45 
prevalence in mammalian systems is currently poorly understood. This modification 46 
accumulates in preimplantation pig embryos12; however, evidence for its presence in mouse 47 
tissues is contradictory13, 14. In this study, we initially aimed to examine if this mark is 48 
detectable in human cell lines using a sensitive immunostaining method that we have 49 
previously employed to detect modified forms of cytosine in vertebrate models15.  50 
To confirm that we can differentiate between m6A-modified mRNAs and 6mA 51 
present on genomic DNA, we performed immunostaining of hPSCs using previously 52 
validated anti-m6A/6mA antibody11 without the DNA denaturation step which is required for 53 
the immunochemical detection of modified bases in genomic DNA11, 15, 16. In these 54 
experiments, we observed prominent m6A staining that disappeared upon pre-treatment of the 55 
samples with RNase A (Supplementary Note). Next, we immunostained several human cell 56 
lines with the same antibody but after treatment of the samples with 4 M HCl, which allows 57 
denaturing double stranded nucleic acids and is routinely used for detection of cytosine 58 
modifications and 6mA in genomic DNA11, 15, 16. In these conditions, we also detected strong 59 
m6A signal in both nuclei and the cytoplasm of hPSCs and cancer cell lines. Notably, high 60 
levels of m6A staining were still evident in the mitotic chromatin in all our samples processed 61 
after RNase A treatment (Fig. 1a; Supplementary Note). To examine if the mitotic staining 62 
we observed indicates the presence of 6mA in the human genome, we performed LC-MS/MS 63 
quantification of 6mA and modified forms of cytosine in the DNA of two hPSCs lines either 64 
cultured under standard conditions or after enrichment for mitotic cells using colcemid 65 
treatment17.  Unlike the species of modified cytosine, 6mA was not detectable by LC-MS/MS 66 
in hPSCs under both experimental conditions even at low parts per million (ppm) levels, 67 
suggesting that this modification, if present in the hPSCs genomes, only occurs at levels 68 
substantially lower than that of 5-formylcytosine18 (Fig. 1b). These results confirmed 69 
previously published LC-MS data indicating the absence of 6mA in the genome of mouse 70 
embryonic stem cells and tissues14.   71 
Attempting to explain the discrepancy between our LC-MS/MS data and 72 
immunostaining results, we hypothesized that the mitotic anti-m6A/6mA antibody-specific 73 
signal was caused by the presence of this modification on the RNA component of R-loops1. 74 
R-loops are specific nucleic acid structures formed by an RNA:DNA hybrid and an unpaired 75 
single stranded DNA that contribute to a number of important biological processes ranging 76 
from transcriptional regulation to DNA repair, and represent a source of genomic instability 77 
in mammalian cells1-4. To test this hypothesis, we immunostained hPSCs using m6A antibody 78 
after treatment of the samples with E. coli RNase H, an enzyme that specifically degrades 79 
RNA molecules present in RNA:DNA hybrids. Notably, mitotic m6A staining significantly 80 
decreased or disappeared in the hPSCs pre-treated with RNase H, corroborating the presence 81 
of this modification on the RNA strand of RNA:DNA hybrids (Fig. 1c-d; Supplementary 82 
Note). Confirming our immunostaining results, we also detected a release of m6A (but not of 83 
ribo-5-methylcytidine, ribo-m5C) to filtrate by stable-isotope dilution ultra-performance 84 
liquid chromatography with tandem mass spectrometry (SID-UPLC-MS/MS) upon treatment 85 
of hPSCs-derived nucleic acids with RNase H (Fig. 1e, f; Supplementary Note). Overall, 86 
these results strongly suggested that m6A modification is associated with the RNA 87 
components of RNA:DNA hybrids in hPSCs. 88 
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To examine the genomic distribution of m6A-marked RNA:DNA hybrids, we 89 
modified a previously published DNA:RNA immunoprecipitation technique (DRIP, referred 90 
here as S9.6 DRIP)2, 19 by replacing anti-RNA:DNA hybrid S9.6 antibody20 with anti-m6A 91 
antibody (designated here as m6A DNA immunoprecipitation, m6A DIP). After validation of 92 
this technique using synthetic spike-in RNA:DNA hybrids and single-stranded 93 
oligonucleotides (Extended Data Fig. 1a-d), we performed m6A DIP in parallel with S9.6 94 
DRIP coupled with high-throughput sequencing on hiPSCs (Fig. 2a; Extended Data Fig. 2). 95 
Although both types of IP resulted in generation of large peak datasets, the majority of m6A 96 
DIP and S9.6 DRIP peaks were not detectable in the control samples pre-treated with RNase 97 
H, confirming that the presence of methylated adenosine is correlated to the RNA component 98 
of R-loops in hPSCs (Fig. 2b, Supplementary Note). Both m6A- and S9.6 peaks exhibited 99 
virtually identical distribution across various genomic features and repetitive elements and 100 
were enriched in transcribed regions of the human genome (Fig. 2c, 3a; Supplementary 101 
Note). Despite the number of m6A DIP peaks being approximately fourfold greater relative to 102 
S9.6 DRIP, both sets of peaks displayed an essentially complete overlap at the sequence level 103 
(Fig. 2b, d). Since the presence of both m6A- and S9.6 peaks was RNase H-dependent, and 104 
the density of S9.6 DRIP reads was noticeably increased across the m6A peaks that do not 105 
overlap with S9.6 peaks (Fig. 2e, Extended Data Fig. 3a), we concluded that difference in the 106 
peak numbers we observed was likely due to different sensitivity of the corresponding 107 
antibodies and, therefore, our results imply that m6A marks most of the RNA:DNA hybrids in 108 
hPSCs. In line with this explanation, m6A DIP demonstrated approximately 3.6-fold more 109 
efficient enrichment for the synthetic m6A-containing RNA:DNA hybrid compared with S9.6 110 
DRIP in our spike-in experiments (Extended Data Fig. 1b). We also observed similar 111 
distribution of common m6A/S9.6- and m6A-only peaks amongst different genomic features 112 
(Extended Data Fig. 3b, c). 113 
 Since the RNase H-sensitive m6A immunostaining signal was particularly high in 114 
mitotic chromatin (Fig. 1a, c), we hypothesized that this modification may accumulate on 115 
RNA:DNA hybrids in a cell cycle-specific manner. To examine the dynamics of m6A-116 
containing R-loops during cell cycle, we performed m6A DIP and S9.6 DRIP on G0/G1, S and 117 
G2/M flow cytometry-sorted hPSCs populations (Extended Data Fig. 4a), followed by 118 
quantitative PCR (qPCR) of LINE-1 repeats and individual intronic sequences enriched in 119 
both m6A- and S9.6 peaks (Fig. 3a; Extended Data Fig. 4b). These experiments demonstrated 120 
that RNA:DNA hybrids accumulate on LINE-1 retrotransposons during S phase, max out at 121 
G2/M and drastically decrease at G0/G1 phases of the cell cycle in hPSCs (Fig. 3b). 122 
Consistently, a recent study demonstrated that retrotransposition active LINE-1-derived 123 
mRNAs are enriched in cells exiting mitosis21. The intronic R-loops were found in high 124 
levels at both S and G2/M phases, but were also significantly depleted at G0/G1 phase (Fig. 125 
3c, d). Importantly, these cell cycle-specific changes were essentially equivalent in both m6A 126 
DIP and S9.6 DRIP, suggesting that m6A is present on RNA:DNA hybrids throughout all 127 
stages of the cell cycle (Fig. 3b-d). Notably, m6A DIP qPCR enrichment substantially 128 
increased on the repetitive and intronic loci upon small interfering RNA (siRNA)-mediated 129 
knock down of RNase H1 in hPSCs (Extended Data Fig. 5a-d). Moreover, the intronic and 130 
repetitive m6A DIP-containing sequences were also enriched in the two round IP (S9.6 DRIP 131 
followed by m6A DIP or m6A RNA IP) procedures, further confirming the presence of m6A 132 
on the RNA components of R-loops (Extended Data Fig. 6a-e). In sum, these results 133 
suggested that the turn-over rates of m6A-marked R-loops vary for cell cycle phases.   134 
Given that deposition of m6A is known to affect stability of mRNAs5-7, we 135 
hypothesized that this mark may also modulate the stability of R-loops. Since siRNA-136 
mediated knockdown of m6A methyltransferase METTL3 led to accumulation of RNA:DNA 137 
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hybrids in hPSCs (Extended Data Fig. 7a-b, 8a-f; Supplementary Note), we next enquired if 138 
any of the previously characterized m6A reader proteins may interact with mitotic chromatin 139 
enriched in m6A-containing R-loops. First, we examined for the presence of the m6A readers 140 
in proteins interacting with RNA:DNA hybrids immuno-precipitated from HeLa cells using 141 
S9.6 antibody22. The analysis showed an enrichment of YTHDF1 – a protein promoting 142 
translation of m6A-containing mRNAs23, HNRNPA2B1 – a nuclear m6A reader previously 143 
implicated in mRNA processing24, and YTHDF2 – an m6A-interacting protein that regulates 144 
degradation of cytoplasmic mRNAs7 as well as METTL3 in the R-loop IP, suggesting that 145 
these proteins interact with RNA:DNA hybrids (Fig. 4a). Our subsequent immunostaining 146 
experiments showed that, while YTHDF1 exhibited predominantly cytoplasmic localization 147 
in both interphase and mitotic hPSCs (Fig. 4b, c) and HNRNPA2B1 was specifically 148 
excluded from the chromatin during mitosis (Fig. 4d, e), YTHDF2 migrated to mitotic 149 
chromatin in dividing hiPSCs (Fig. 4f, g). Moreover, the nuclear fraction of YTHDF2 150 
exhibited a high degree of co-localization with RNA:DNA hybrids in interphase cells 151 
(Extended Data Fig. 9a-e). In line with this, we also observed preferential interaction of 152 
YTHDF2 with m6A-containing synthetic RNA:DNA substrates in electrophoretic mobility-153 
shift assays (Extended Data Fig. 9f, g; Supplementary Note) and in MicroScale 154 
Thermophoresis (MST) analysis that demonstrated that YTHDF2 shows comparable 155 
dissociation constant values for its interaction with m6A-marked single-stranded RNA and 156 
m6A-RNA:DNA duplexes in this assay (Fig. 4h). Furthermore, YTHDF2 ChIP showed that 157 
this m6A reader interacts with both LINE-1s and intronic genomic regions enriched in 158 
RNA:DNA hybrids in these cells (Extended Data Fig. 10a).  In contrast, we did not observe 159 
any interaction of HNRNPA2B1 with LINE-1 repeats but were able to detect binding of this 160 
protein to R-loops-containing intronic regions in ChIP experiments (Extended Data Fig. 10b). 161 
Interestingly, although the recruitment of both these proteins to R-loop-containing loci was 162 
reduced upon METTL3 knock-down, confirming their interaction with m6A in chromatin-163 
bound RNAs (Extended Data Fig. 10c, d), the accumulation of YTHDF2 (but not of 164 
HNRNPA2B1) at LINE-1s and intronic loci was dramatically increased in siRNaseH1 165 
hPSCs, strongly suggesting the association of this m6A reader with R-loops in vivo (Extended 166 
Data Fig. 10e, f). To assess the functional significance of YTHDF2 migration to mitotic 167 
chromatin, we performed its siRNA-mediated depletion (siYTHDF2) in hPSCs. S9.6 DRIP- 168 
and m6A DIP qPCR showed a significant enrichment in both repetitive and individual 169 
intronic R-loops sequences in siYTHDF2 hPSCs relative to siCTL cells (Extended Data Fig. 170 
10g-i). To further confirm these results, we next assessed the levels of R-loops in YTHDF2 171 
knockout (KO) HAP125 cells expressing a truncated version of this protein that does not co-172 
localize with mitotic chromatin (Fig. 5a, Supplementary Note). These experiments showed 173 
both the elevated levels of S9.6 immunostaining and dramatic 5-50 fold increase in R-loops 174 
at Alu-S, Alu-Y, LINE-1s and intronic sequences in YTHDF2 KO compared with isogenic 175 
wild type (WT) parental HAP1 cells (Fig. 5b, c). Moreover, YTHDF2 depletion in HAP1 176 
cells also resulted in increased accretion of m6A on RNA:DNA hybrids (Fig. 5d) and cell 177 
growth retardation (Fig. 5e). Subsequent analysis of recently published Ythdf2 constitutive 178 
knockout26 mice-derived neural stem cells (mNSCs) confirmed these results demonstrating 179 
increased levels of S9.6 immunostaining and accumulation of RNA:DNA hybrids in LINE-180 
1open reading frames upon depletion of Ythdf2 in this system (Fig. 5f, g).  In line with these 181 
results, YTHDF2 KO HAP1 cells displayed an increased accumulation of a marker for DNA 182 
double-strand breaks, phosphorylated (ser139) histone variant H2AX (γH2AX)27 both at the 183 
nucleus-wide level and at R-loop-enriched loci (Fig. 6a, b). Correspondingly, we also 184 
observed elevated levels of γH2AX staining in the cortex of Ythdf2 KO embryos and Ythdf2 185 
KO mNSCs (Fig. 6c) as well as, to a lesser extent, in hPSCs upon siRNA-mediated 186 
depletions of METTL3 and HNRNPA2B1 (Fig. 6d, Supplementary Note). Moreover, the 187 
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γH2AX intensity significantly decreased upon overexpression of RNase H1 in YTHDF2 KO 188 
HAP1 cells (Fig. 6e). Overall, these results suggest that YTHDF2 prevents accumulation of 189 
m6A-containing RNA:DNA hybrids contributing to inhibition of R-loop-dependent DNA 190 
damage in mammalian cells. Correspondingly, YTHDF2 has been previously identified as 191 
one of the factors promoting genomic stability in a genome-wide siRNA screen28. 192 
The nature of the techniques we used for m6A mapping is limited by the specificity 193 
and sensitivity of the available antibody. Even so, our results show that m6A modification is 194 
present on the RNA within R-loops, potentially contributing to various aspects of their 195 
biology (Supplementary Note). In this context, the YTHDF2-mediated regulation of 196 
RNA:DNA hybrids may represent a specific mechanism of preventing accumulation of co-197 
transcriptional R-loops during mitosis. Together with previously described factors 198 
suppressing formation of these structures29-31, YTHDF2 plays a role in safeguarding genomic 199 
stability.  200 
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Figure Legends: 302 
Fig. 1. m6A marks the RNA components of RNA:DNA hybrids in hPSCs. (a) m6A and 5-303 
methyldeoxycytosine (5mC) co-immunostaining of KaryoMAX-treated hiPSCs without 304 
RNases and after RNase A treatment. Merged images are shown. Mitotic cells are arrowed. 305 
(b) The ratios of the indicated deoxynucleotides obtained from the quantification of LC-306 
MS/MS peaks in KaryoMAX-treated and untreated hiPSCs/hESCs DNA. Data are means ± 307 
SD, n=2 MS experiments. (c) Immunostaining of hiPSCs using anti-m6A and anti-phospho-308 
Histone H3 antibodies without RNases and after RNase A or combined RNases A/H 309 
treatments. Merged views are presented. (d) Box plots showing quantification of m6A signal 310 
intensity in the interphase and mitotic hiPSCs at indicated immunostaining conditions. The 311 
elements of the box plots are: center line, median; box limits, upper and lower quartiles; 312 
whiskers, minimum and maximum of all the data; n=20 nuclei for each condition. 313 
Significance was determined by unpaired two-tailed Student’s t-test. No adjustments were 314 
made for multiple comparisons. (e) Schematic illustrating design of the experiment on SID-315 
UPLC-MS/MS analysis of hPSCs-derived nucleic acids released and retained upon RNase H 316 
treatment. (f) SID-UPLC-MS/MS quantification of m6A and ribo-m5C in the fractions of 317 
hESCs- and hiPSCs-derived nucleic acids released upon RNase H treatment. Data are shown 318 
as means ± SD, n=4/n=3 MS experiments for m6A/ribo-m5C quantification. Scale bars are 10 319 
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μm in (a) and 5 μm in (c). KaryoMAX treatment was used to enrich hPSCs for mitotic cells 320 
in (a, b). The experiments shown in (a, c) were repeated independently 6 times with similar 321 
results.  322 
Fig. 2. m6A is present on the majority of the RNA:DNA hybrids in hPSCs. (a) Schematic 323 
illustrating the m6A DIP technique. See also Extended Data Fig. 2. (b) The coverage plots of 324 
m6A DIP and S9.6 DRIP densities (CPK) in the intron of CAMTA1-201 gene. m6A DIP and 325 
S9.6 DRIP peaks are marked with red and blue rectangles. (c) Distribution of m6A and S9.6 326 
peaks at the indicated genomic features in hiPSCs. (d) Venn diagram illustrating an overlap 327 
between m6A DIP and S9.6 DRIP consensus peaks in REBL-PAT hiPSCs. (e) Heatmaps 328 
showing the distribution of density of m6A DIP and S9.6 DRIP reads across genomic regions 329 
containing the peaks (3 kb around peak center) of the three categories: m6A peaks 330 
overlapping with S9.6 peaks (m6A/S9.6), m6A peaks that do not overlap with S9.6 DRIP 331 
peaks (m6A only) and S9.6 peaks that do not correspond to m6A peaks (S9.6 only). The color 332 
of each line represents the density of reads for a given peak. The width of the heatmaps is 333 
normalized by peak length. Median numbers of reads per normalized region within each of 334 
the peak subsets are plotted over the top of the heatmaps. As the exact mode of genomic 335 
distribution of m6A-containing RNA:DNA hybrids was initially unknown, we performed 336 
detection of both narrow and broad peaks in the datasets. The results shown were obtained 337 
from analyses of the narrow m6A and S9.6 peaks.    338 
Fig. 3. RNA:DNA hybrids exhibit cell cycle-specific dynamics in hPSCs. (a) The m6A DIP 339 
and S9.6 DRIP consensus narrow peak counts of the indicated repetitive elements in hiPSCs. 340 
(b) The results of m6A DIP and S9.6 DRIP qPCR of the indicated repeats performed on 341 
hiPSCs sorted at different cell cycle phases. Generic primers amplifying evolutionarily young 342 
L1Hs were used. (c, d) The results of S9.6 DRIP (c) and m6A DIP qPCR (d) of the 343 
RNA:DNA peaks localized in the introns of the indicated genes (See Extended Data Fig. 9b) 344 
performed on hiPSCs sorted at different phases of the cell cycle. Data are means ± SD, n=3 345 
independent experiments in (b-d).  346 
Fig. 4. m6A reader proteins interact with RNA:DNA hybrids. (a) Western blot of RNA:DNA 347 
hybrids protein co-IP probed with indicated antibodies. Top1 and Lamin B1 serve as positive 348 
and negative controls for R-loop IP, respectively. The experiments were repeated 349 
independently 2 times for METTL3 and 3 times for other proteins with similar results. The 350 
blots were cropped. The full scans of the blots are shown in Source Data 1. (b, c) 351 
Immunostaining of hiPSCs using anti-YTHDF1 and anti-phospho-Histone H3 antibodies 352 
imaged at two different magnifications. (d, e) Immunostaining of hiPSCs for HNRNPA2B1 353 
and m6A imaged at two different magnifications. (f, g) Immunostaining of hiPSCs for 354 
YTHDF2 and phospho-Histone H3 imaged at two different magnifications. Merged views 355 
and YTHDF1/HNRNPA2B1/YTHDF2 channels (b, d, f) or merged views and individual 356 
channels (c, e, g) are shown. The locations of the views shown in (c, e, g) are marked with 357 
dotted rectangles in (b, d, f). Scale bars are 10 μm. The experiments shown in (b-g) were 358 
repeated independently 4 times with similar results. (h) Microscale thermophoresis binding 359 
curves for YTHDF2 interaction with m6A-containing/non-modified RNA:DNA hybrid and 360 
m6A-marked/non-modified ssRNA synthetic substrates The binding is shown as fraction 361 
protein bound as a function of substrate concentration. Binding curves are fitted to the data 362 
points from experiments for m6A-containing (filled circles/triangles) and unmodified (open 363 
circles/triangles) substrates. Dissociation constant values are shown for each of the 364 
interactions. Error bars show SD, the centre values are means, n=6 independent series of 365 
experiments.  366 
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Fig. 5. YTHDF2 depletion leads to accumulation of R-loops, increased accretion of m6A on 367 
RNA:DNA hybrids and cell growth retardation. (a) Immunostaining of WT and YTHDF2 KO 368 
HAP1 for YTHDF2 and phospho-Histone H3. The experiments were repeated independently 369 
3 times with similar results. (b) Immunostaining of WT and YTHDF2 KO HAP1 for R-loops 370 
alongside the quantification of S9.6 nuclear signal. (c) DRIP qPCR of the indicated 371 
sequences performed on WT and YTHDF2 KO HAP1. RANBP17 and HECW1 downstream 372 
regions lacking DRIP peaks were used as controls. (d) SID-UPLC-MS/MS quantification of 373 
m6A and ribo-m5C in S9.6-IPs performed on WT and YTHDF2 KO HAP1 and normalized for 374 
dA or rA. RNase H-pre-treated samples were used as controls. Data are means ± SD, n=5 375 
(left) and n=7 (right panel) measurements of 4 independent samples. (e) The growth curves of 376 
WT and YTHDF2 KO HAP1. (f) Immunostaining of WT/Ythdf2 KO mNSCs for R-loops 377 
alongside the quantification of S9.6 nuclear signal. (g) DRIP and m6A DIP qPCR of mouse 378 
LINE-1 ORF1 performed on WT and Ythdf2 KO mNSCs. Individual channels (a) or S9.6 379 
channel (b, f) with merged views are shown. Scale bars are 10 μm. Data are means ± SD, n=3 380 
independent experiments in (c, e, g). The elements of the box plots (b, f) are: centre line, 381 
median; box limits, upper and lower quartiles; whiskers, minimum and maximum of all the 382 
data; n, sample size, ***p < 0.0001. Significance was determined by unpaired two-tailed 383 
Student’s (b, f) or unpaired two-tailed Welch's (e) t-test.  384 
Fig. 6. YTHDF2 depletion leads to elevated levels of H2AX phosphorylation in human and 385 
mouse cells. (a) Representative images of WT and YTHDF2 KO HAP1 cells immunostained 386 
for γH2AX, and quantification of γH2AX signal intensity in these cells. (b) The results of 387 
γH2AX ChIP qPCR of the indicated sequences performed on WT and YTHDF2 KO HAP1. 388 
Generic primers amplifying Alu elements from the indicated families and evolutionarily 389 
young L1Hs were used. Data are means ± SD, n=3 independent experiments. (c) 390 
Representative images of WT/Ythdf2 KO embryonic brain cortex and mNSCs immunostained 391 
for γH2AX alongside quantification of γH2AX signal intensity in these tissues/cells. (d) 392 
Immunostaining of siCTL, siMETTL and siHNRNPA2B1 hPSCs for γH2AX and 393 
quantification of γH2AX signal intensity in these cells. (e) Representative images of 394 
YTHDF2 KO HAP1 cells transfected with GFP-RNase H1 and GFP-only expression 395 
constructs immunostained for γH2AX, alongside the quantification of γH2AX signal 396 
intensity in the GFP-positive cells. P value is indicated. Examples of the nuclei used for 397 
signal quantification are marked with dotted shapes. Merged images and S9.6 channel views 398 
are shown in (a, c-e). Scale bars are 10 μm. The elements of the box plots shown in (a, c-e) 399 
are: centre line, median; box limits, upper and lower quartiles; whiskers, minimum and 400 
maximum of all the data, n, sample size, ***p < 0.0001. Significance was determined by 401 
unpaired two-tailed Student’s t-test, no adjustments were made for multiple comparisons. 402 
 403 
Methods 404 
Cell culture, flow cytometry and RNA-interference-mediated knockdowns. 405 
REBL-PAT hiPSCs and HUES7 hESCs were maintained in Essential 8™ (E8) medium with 406 
supplement (#A1517001) on Matrigel™-coated tissue culture flasks at 37 °C with 5 % CO2. 407 
Use of the HUES7 hESC line was approved by the UK Medical Research Council Steering 408 
Committee, in association with the UK Stem Cell Bank. Cells were passaged every 3–4 d 409 
using TrypLE™ Select Enzyme (#12563029). hiPSCs were treated with 1:100 dilution of 410 
KaryoMAX® Colcemid™ Solution (Thermo Fisher Scientific, catalogue number 15212012) 411 
for 3 h. HeLa, LN-18 and U87MG cells were maintained on DMEM (GIBCO) supplemented 412 
with 10 % bovine serum. G0/G1, S and G2/M phases flow cytometry sorting was performed 413 
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according to the previously described method32. Briefly, enzymatically dissociated hPSCs 414 
were washed in PBS and fixed in 70 % ethanol for 2 h, washed with PBS again and stained 415 
with 10 µg/ml propidium iodide (PI) (Sigma-Aldrich, catalogue number P3566) in PBS 416 
supplemented with 0.1 % Triton X-100 and 100 µg/ml RNase A (Qiagen, catalogue number 417 
19101). PI treated hPSCs were sorted based on the DNA content into G0/G1, S and G2/M cells 418 
using Beckman Coulter Astrios EQ and Beckman Coulter Kaluza 2.1 software. For METTL3 419 
and YTHDF2 depletion, hiPSCs were transfected with 50 pmol of siRNA duplexes against 420 
human METTL3 (DharmaconTM, catalogue number 56339), human HNRNPA2B1 421 
(Thermofisher, Catalogue number 4390824 siRNA, ID: s6714), human YTHDF2 (Qiagen, 422 
catalogue number GS51441), human RNase H1 (Dharmacon, Catalogue number M-012595-423 
00-0010) and nontargeting siRNA #2 (Thermo Fisher Scientific, catalogue number D-424 
001210-02) using DharmaFECTTM (GE Lifesciences) in antibiotic-free medium. Cells were 425 
collected for analysis 72 h after transfection. Expression of METTL3, HNRNPA2B1, RNase 426 
H1 and YTHDF2 was analysed by qPCR, according to standard procedures. Gene expression 427 
was normalized by comparison to levels of GAPDH gene expression. The primers used for 428 
qPCR are listed in Supplementary Table 1.  429 
YTHDF2 KO (CRISPR/Cas9-mediated deletion of 140 bp in the exon 3 leading to frameshift 430 
and generating premature stop codon) HAP1 cells (Horizon Discovery, catalogue number 431 
HZGHC006678c001) and their isogenic wild type parental HAP1 cells (Horizon Discovery) 432 
were cultured on DMEM/F12 (Gibco Life Technologies, Catalog number 11320033) 433 
supplemented with 20 % heat-inactivated foetal bovine serum containing 1 % pen/strep at 37 434 
°C in a humidified incubator with 5 % CO2. Culture medium was changed daily and the cells 435 
were passaged using trypsin every 48 h. For determining the growth curve cells were counted 436 
using haemocytometer. Statistical significance was determined using 2-tailed t-test following 437 
assessment of the variance with F-test. The deletion in the 3rd exon of YTHDF2 gene was 438 
validated by PCR (See Supplementary Table 1 for primer sequences) and by sequencing. 439 
For overexpression of RNase H1 in mammalian cells we C-terminally eGFP-tagged human 440 
RNASEH1 (nuclear isoform) pEGFP‐RNASEH1 plasmid33. This construct was a gift from 441 
Andrew Jackson & Martin Reijns (Addgene plasmid # 108699 ; 442 
http://n2t.net/addgene:108699 ; RRID:Addgene_108699). pmaxGFPTM (Lonza) was used as a 443 
control GFP-only plasmid.   444 
Animals and Ythdf2 KO mouse model. Generation of the Ythdf2 conditional 445 
knockout mice, followed by cre-mediated deletion and derivation of mNSCs from E14.5 446 
embryonic forebrains were described previously26. All mouse experiments were approved by 447 
the Norwegian Animal Research Authority by Norwegian Food Safety Authority and done in 448 
accordance with institutional guidelines at the Centre for Comparative Medicine at Oslo 449 
University Hospital. Animal work was conducted in accordance with the rules and 450 
regulations of the Federation of European Laboratory Animal Science Association’s 451 
(FELASA). 452 
Immunocytochemistry, immunohistochemistry, confocal microscopy and image 453 
quantification. Immunocytochemistry and immunohistochemistry were performed as 454 
described15, 34. Sections of paraffin-embedded E14.5 wild type and Ythdf2 KO mouse 455 
embryonic brain were used for γH2AX immunohistochemistry. The sections were dewaxed 456 
according to standard procedures. Cells were fixed in 4 % formaldehyde for 15 min. Cells 457 
and tissue sections were permeabilised with PBS containing 0.5 % Triton X-100 for 15 min. 458 
After permeabilisation, cells were treated with 25 mg/ml RNase A (Qiagen, catalogue 459 
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number 19101) in PBS or with a mixture of 25 mg/ml RNase A and 10 U of RNase H in 1X 460 
RNase H buffer (NEB, catalogue number M0297S) overnight at 37 °C. DNase I (Qiagen, 461 
catalogue number 79254) treatment (20 U per sample) was carried out for 4 h at room 462 
temperature. The samples were incubated in 4N HCl for 1 h at 37 °C. Competition 463 
experiments were performed as described previously15 using N6-Methyl-2'-deoxyadenosine-464 
5'-triphosphate (Trilink, catalogue number NU-949S) or unmodified dATP and dTTP from 465 
dNTP set (NEB, catalogue number N0446S). Immunostaining for RNA:DNA hybrids was 466 
performed according to previously published protocol35 using S9.6 antibody (Merck 467 
Millipore, catalogue number MABE1095). The antibodies used for immunochemistry and 468 
their dilutions are provided in Supplementary Note. Control staining without primary 469 
antibodies produced no detectable signal. Images (500 nm optical sections) were acquired 470 
with a Zeiss LSM 700 AxioObserver confocal microscope using a Plan-Apochromat 63x/1.40 471 
Oil DIC M27 objective and processed using Image J and Adobe Photoshop. 2.5XD signal 472 
intensity plots and intensity profiles were generated using ZEN Zeiss LSM 700 imaging 473 
software as described previously15, 36. Confocal raw data are available upon request. Co-474 
localization coefficients were determined using the inbuilt analysis function of ZEN as 475 
described15, 34. Quantification of the m6A, γH2AX and S9.6 signal intensities was performed 476 
according to the previously described method34. Mean values of the average of 18-60 nuclei 477 
signal intensities were calculated for each experimental point.  478 
Liquid chromatography-tandem mass spectrometry (LC-MS/MS). DNA and total 479 
RNA were isolated according to standard procedures. Up to 15 µg of purified DNA was 480 
digested to nucleosides for subsequent LC-MS analysis. Genomic DNAs and RNAs were 481 
digested to nucleosides by treatment with the Nucleoside Digestion Mix (NEB, M0649S) 482 
overnight at 37 °C. LC-MS/MS analysis was performed in duplicate by injecting digested 483 
DNAs and RNAs on an Agilent 1290 UHPLC equipped with a G4212A diode array detector 484 
and a 6490A Triple Quadrupole Mass Detector operating in the positive electrospray 485 
ionization mode (+ESI). UHPLC was carried out using a Waters XSelect HSS T3 XP column 486 
(2.1 × 100 mm, 2.5 µm) with the gradient mobile phase consisting of methanol and 10 mM 487 
aqueous ammonium formate (pH 4.4). MS data acquisition was performed in the dynamic 488 
multiple reaction monitoring (DMRM) mode. Each nucleoside was identified in the extracted 489 
chromatogram associated with its specific MS/MS transition: dC at m/z 228→112, d5mC at 490 
m/z 242→126, d5hmC at m/z 258→142, d5fC at m/z 256→140, dA at 252→136, d6mA at 491 
266→150, rC at m/z 244→112, m5C at 258→126, Cm at 258→112, rA at 268→136, m1A at 492 
282→150, Am at 282→136, m6A at 282→150, and m62A at 296→164. External calibration 493 
curves with known amounts of the corresponding nucleosides were used to calculate the 494 
ratios within the samples analysed. 495 
Stable-isotope dilution ultra-performance liquid chromatography with tandem 496 
mass spectrometry (SID-UPLC-MS/MS). The cells were resuspended in ice-cold buffer 497 
containing 10 mM Tris-HCl, 5 mM Na2EDTA, 0.15 mM deferoxamine mesylate (pH 8.0) 498 
and 0.5 % SDS. The samples were incubated at 37 °C for 30 min followed by addition of 2.5 499 
mg/ml Proteinase K and further incubation at 37 °C for 1.5 h. The nucleic acids were isolated 500 
using phenol/chloroform extraction and precipitated using ethanol. The precipitate was 501 
removed to another tube with plastic spatula, washed with 70 % ethanol and dissolved in 502 
MilliQ-grade deionized water. 5-10 µg of nucleic acids were treated with 5 U of RNase H 503 
(NEB) overnight in RNase H Reaction Buffer (NEB) at 37 °C. After incubation samples were 504 
ultrafiltered using Amicon Ultra-0.5 MWCO 3 kDa Centrifugal Filter (Merck) at 14000 g for 505 
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10 min. Subsequently, the samples were rinsed twice with MilliQ-grade deionized water 506 
(14000 g for 15 min). To recover the nucleic acids the filter was placed upside down in a 507 
clean microcentrifuge tube and centrifuged at 1000 g for 3 min. The ultrafiltrates containing 508 
released (oligo)nucleotides with molecular weight less than 3 kDa and the remaining nucleic 509 
acids were treated with 1U of nuclease P1 for 1 h in a buffer containing 200 mM ammonium 510 
acetate, 0.2 mM ZnCl2 (pH 4.6) and 10 μg/sample tetrahydrouridine at 37°C, followed by 511 
addition of 10 % NH4OH and 1.3 U of alkaline phosphatase and subsequent additional 1 h 512 
incubation at 37 °C. Chromatographic analysis was performed using previously described 513 
method37 adapted for determination of m6A, mrC and adenosine (See details in 514 
Supplementary Note).  515 
 RNA:DNA hybrids and protein co-immunoprecipitation with S9.6 antibody was 516 
performed from non-cross-linked HeLa cells as described previously22. The genomic DNA 517 
was isolated from HeLa cells and sonicated as described38. The western blots of RNA:DNA 518 
hybrid IP samples were probed with the following antibodies: Top1 (Abcam, catalogue 519 
number ab109374, dilution 1:2000), YTHDF1 (ProteinTech, catalogue number 17479-1-AP, 520 
dilution 1:1000), YTHDF2 (ProteinTech, catalogue number 24744-1-AP, dilution 1:500), 521 
METTL3 (Bethyl Laboratories, catalogue number A301-567A, dilution 1:2000),  522 
HNRNPA2B1 (Novus, catalogue number NB120-6102SS, dilution 1:500) and Lamin B1 523 
(Abcam, catalogue number ab16048, dilution 1:2000). Images were acquired by 524 
chemiluminescence using autoradiography. 525 
m6A DIP and S9.6 DRIP. Genomic DNA was isolated from REBL-PAT hiPSCs by 526 
SDS/Proteinase K treatment at 37 °C followed by incubation with 100 µg/ml RNase A 527 
(Qiagen, catalogue number 19101) for 30 min in lysis buffer, phenol-chloroform extraction 528 
and ethanol precipitation. The DNA was fragmented to 300-600 bp using Covaris S2 529 
ultrasonicator (Covaris Inc). Genomic DNA of the control samples was treated with 10 U of 530 
RNase H (NEB, catalogue number M0297S) in 1x RNase H buffer overnight at 37 °C before 531 
the immunoprecipitation. 10 μg of genomic DNA was used for immunoprecipitation. S9.6 532 
DRIP was carried out essentially as described in the previously published protocol39 using 533 
S9.6 antibody (Merck Millipore, catalogue number MABE1095) and anti-mouse magnetic 534 
Dynabeads (Invitrogen). m6A DIP was performed using anti-m6A rabbit polyclonal antibody 535 
(Synaptic systems, catalogue number 202003) and magnetic anti-rabbit Dynabeads 536 
(Invitrogen, M-280; polyclonal sheep anti-rabbit IgG; catalogue number 10716653) with 537 
denaturation step before the IP (10 min at 95º C) analogously to meDIP technique40 538 
(Supplementary Fig. 6). The corresponding primary IgG-only and secondary IgG only 539 
(Dynabeads only) DRIP reactions were used in control immunoprecipitations. For the two 540 
round (S9.6 DRIP followed by m6A DIP) DRIP/DIP, approximately 500 ng of the nucleic 541 
acids recovered from multiple DRIP reactions performed in parallel were used for m6A DIP 542 
followed by qPCR analysis. For S9.6 DRIP followed by m6A RIP experiment, nucleic acids 543 
recovered from DRIP were denatured for 30 min at 95 ºC followed by digestion of the DNA 544 
components of RNA:DNA hybrids using Turbo DNase (Invitrogen, catalogue number: 545 
AM1907) for 30 min at 37 ºC. After inactivation of DNase, approximately 100 ng of the 546 
recovered RNA was used for the m6A RIP performed using EpiMark® N6-Methyladenosine 547 
Enrichment Kit (NEB, catalogue number E1610S). The eluted RNA was reverse transcribed 548 
using SuperScript III Reverse Transcriptase (Invitrogen, catalogue number 2072529A) and 549 
random hexamers (Invitrogen, catalogue number 1831815) and analysed by qPCR. IgG-only 550 
reactions and reactions carried out without reverse transcription were used as controls.  551 
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For validation of m6A-DIP using synthetic oligonucleotides, 0.1-1 pmol of m6A-containing- 552 
and non-modified RNA:DNA hybrids and individual single stranded RNA or DNA 553 
oligonucleotides were spiked-in with 5 µg of mouse genomic DNA. The RNA and DNA 554 
oligonucleotides used for spike-in experiments and primers used to amplify spike-in controls 555 
are listed in Supplementary Table 1. The RNA oligonucleotides were synthesised by 556 
Dharmacon. To generate RNA:DNA hybrids, the RNA and DNA oligonucleotides were 557 
mixed in equimolar concentrations, incubated for 20 min at 98º C, slowly cooled down in a 558 
heating block and placed on ice. Quantitative PCR analysis of m6A DIP and S9.6 DRIP 559 
samples was carried out with SYBR Green PCR Master Mix (Sigma) according to standard 560 
procedures. Fold enrichment was calculated as 2ddCt, where dCt=Ct(enriched)-Ct(input) and 561 
ddCt=dCt – Ct (IGG). The primers used for DRIP/DIP-qPCR and qPCR analysis of the 562 
corresponding transcripts are listed in Supplementary Table 1.  The primers for α-satellites 563 
were obtained from Novus (catalogue number NBP1-71654SS). Generic primers amplifying 564 
Alu elements from the indicated families and evolutionarily young L1Hs were used. Human 565 
LINE-1 primers were designed to detect L1PA1 and L1PA2 classes of these retroelements. 566 
The primers for mouse LINE-1 ORF1 were previously published41. The primers used for 567 
DRIP-qPCR of Alu-Y, Alu-S and LINE-1s were also employed for qPCR. Gene expression 568 
was normalized by comparison to levels of GAPDH gene expression. 569 
Chromatin immunoprecipitation (ChIP) was performed using EZ-Magna ChIP™ 570 
A/G Chromatin Immunoprecipitation Kit (Merck, catalogue number 17-10086) according to 571 
manufacturer’s instructions using anti-YTHDF2 rabbit polyclonal (ProteinTech, catalogue 572 
number 24744-1-AP), anti-HNRNPA2B1 mouse monoclonal (Novus, catalogue number 573 
NB120-6102SS) and anti-γH2AX mouse monoclonal (Merck, catalogue number 05-636, 574 
clone JBW301) primary antibodies. ChIP was analysed by quantitative PCR carried out with 575 
SYBR Green PCR Master Mix (Sigma) according to standard procedures. Fold enrichment 576 
was calculated as 2ddCt, where dCt=Ct(enriched)-Ct(input) and ddCt=dCt – Ct (IGG). The 577 
primers used for DRIP-qPCR were also used for ChIP-qPCR analysis. 578 
Purification of recombinant YTHDF2. Full-lengths YTHDF2 was cloned into pET-579 
28b with N-terminal His-tag (Genescript). The plasmid was expressed in BL21(DE3) cells 580 
and incubated with LB-medium (Puls medical, 244610) with sorbitolat at 37° C until OD600 581 
0.7. Expression was induced with 300 µM IPTG overnight at 18° C. Cells were pelleted by 582 
centrifugation at 3000 g for 10 min at 4° C, resuspended in lysis buffer (50 mM Tris pH 8.0, 583 
300 mM NaCl, 10 mM ME, 10 mM imidazole) and sonicated. After sonication, the extract 584 
was centrifuged at 19000 g for 20 min at 4° C. The supernatant was loaded to Protino® Ni-585 
NTA agarose prepared as described by the producer (Macherey-nagel, 745400.100) in a 50 586 
ml tube and incubated at 4° C with rotation for 30 min. After centrifugation at 3000 g for 2 587 
min, the Ni-agarose-bound YTHDF2 was washed with the buffer containing 50 mM Tris pH 588 
8.0, 300 mM NaCl, 10 mM ME and 50 mM imidazole. Recombinant YTHDF2 was eluted 589 
with 5 washes (1.5 ml each) of elution buffer (50 mM Tris pH 8.0, 300 mM NaCl, 10 mM 590 
ME and 300mM imidazole).     591 
 Microscale thermophoresis (MST) was employed to study the interaction of 592 
YTHDF2 with modified or unmodified- RNA and RNA:DNA hybrid synthetic substrates 593 
used in EMSA experiments. The purified full-lengths YTHDF2 with N-terminal His-tag was 594 
labelled with the NT-647 RED-tris-NTA dye for His-tagged proteins following the 595 
recommended labelling protocol (Nanotemper Technologies). 100 μl of 200 nM protein in 596 
PBS buffer was mixed with 100 μl of 100 nM dye in the supplemented PBS-T buffer and 597 
incubated at room temperature for 30 minutes. The labelled protein was then added to a 1:1 598 
dilution series of the respective substrate in UltraPure DNase/RNase-Free Distilled Water 599 
(FisherScientific) to a final concentration of 50 nM. The different protein-substrate samples 600 
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were loaded into standard NT.115 MST capillaries (Nanotemper). Fluorescence profiles were 601 
measured at 25° C in a Monolith NT.115 instrument using the red channel. Data was 602 
collected at 20 % (single-strand substrates) or 40 % (hybrid substrates) MST power and 60 % 603 
excitation power. The changes in fluorescence (ΔFnorm) due to thermophoresis were measured 604 
as the signal difference between time points 0 and 10 seconds. Data were normalized and 605 
plotted as a function of the ligand concentration, and a binding curve was fitted to the average 606 
of six independent dilution series of each substrate.  607 
Library preparation and high throughput sequencing. Sequencing libraries were 608 
prepared according to the NEB Next DNA Ultra Library Preparation Kit for Illumina (NEB, 609 
E7370). DNA was sonicated to 400-600 bp (Covaris S2) and adapters were ligated (NEB, 610 
E73355S) according to the protocol. Adapter ligated DNA was digested with USER enzyme 611 
as stated in the protocol. Following immunoprecipitation, the enriched adapter ligated DNA 612 
was amplified for 15 cycles and libraries were quantified using the Kapa Library 613 
Quantification Kit (Kapa Biosystems, KK4823). Sequencing was performed using the 614 
Illumina NextSeq500 platform to generate 2 x 150 bp reads. Primary IgG-only DRIP 615 
reactions resulted in the DNA amounts insufficient for successful library production even 616 
with maximum number (15) of amplification cycles recommended by NEB. 617 
Whole transcriptome sequencing. Total RNA was isolated from REBL-PAT hiPSCs 618 
according to standard procedures. RNA-seq libraries were constructed using the Illumina 619 
TruSeq Stranded Total RNA sample preparation kits (Illumina, Inc., San Diego, CA), 620 
according to the manufacturers guidelines, and then sequenced on Illumina HiSeq 4000 621 
generating 20–50 million 75 bp paired-end reads per sample.  622 
Bioinformatics analysis. The 150 bp Illumina paired end reads were trimmed using 623 
Skewer to remove low quality sequences42. Reads that passed filtering were aligned to the 624 
human Ensembl genome (build hg38.89) using BWA with default parameters43. As each 625 
biological sample was split across multiple lanes of sequencing, the corresponding 626 
alignments were merged with Samtools44 and de-duplicated to remove PCR artefacts with 627 
picard-tools MarkDuplicates45. The impact of each pulldown was assessed using 628 
Phantompeakqualtools46 and the highly modified regions (HMRs, peaks) were identified 629 
using MACS2.1.146, 47. As the exact mode of genomic distribution of m6A-containing 630 
RNA:DNA hybrids was initially unknown, we performed detection of both narrow and broad 631 
peaks using -q 0.01 settings for narrow peaks and --broad-cutoff 0.1 (q 0.01) for broad peaks. 632 
High confidence peaks and consensus peaks were identified using the bioconductor package 633 
DiffBind48. We performed peak calling against input DNA and against secondary IgG-only 634 
control samples. More than 96 % of the m6A DRIP peaks called against input were also 635 
identified using IgG-only controls. Peaks called against input were used for further analysis. 636 
Consensus peaks were defined using the dba.peakset() function to select for peaks 637 
overlapping in both replicates. In each instance the replicate sample BAM/bed files along 638 
with the corresponding input samples were used as input. Additional details of bioinformatics 639 
analysis are provided in Supplementary Note. Details on software and data deposition are 640 
listed in the Life Sciences Reporting Summary. 641 
Statistics and reproducibility. At least 2 and typically 3 independent experiments were 642 
carried out for most of the assays. DRIP and DIP were performed in two and RNaseq in three 643 
biologically independent experiments. All experiments were replicated independently. We 644 
observed generally good correlation between the replicates. Statistical tests used for 645 
individual experiments are described in corresponding figure legends. For quantification of 646 
the m6A, γH2AX and S9.6 signal intensities, statistical significance was determined using 647 
unpaired two-tailed Student’s t-test or unpaired two-tailed Welch's t-test. Signal intensity and 648 
qPCR data were plotted and analyzed in GraphPad Prism 7.04. 649 
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Ethics statement: Use of the HUES7 hESC line was approved by the UK Medical Research 650 
Council Steering Committee, in association with the UK Stem Cell Bank. All mouse 651 
experiments were approved by the Norwegian Animal Research Authority by Norwegian 652 
Food Safety Authority and done in accordance with institutional guidelines at the Centre for 653 
Comparative Medicine at Oslo University Hospital. Animal work was conducted in 654 
accordance with the rules and regulations of the Federation of European Laboratory Animal 655 
Science Association’s (FELASA). 656 
Data and materials availability: The confocal raw data that support the findings of this 657 
study are available from the corresponding author upon request due to size considerations. 658 
The deep sequencing data have been deposited in the NCBI Sequence Read Archive (SRA) 659 
with the Bioproject ID: PRJNA474076 660 
(https://submit.ncbi.nlm.nih.gov/subs/sra/SUB4074125). The annotated bed files have been 661 
deposited to the following online repository (https://bitbucket.org/ADAC_UoN/adac1075-662 
bed-files/src). The in-house scripts used for the analysis can be found in the following online 663 
repository (https://bitbucket.org/ADAC_UoN/adac0175-code/src).  664 
Code availability: The in-house scripts used for the analysis can be found in the following 665 
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